Given our previous findings that combined ACY-1215/carfilzomib treatment result in acute ER stress and apoptosis in BRAFMT colorectal cancer (14) and the recent clinical development of the GRP78 inhibitor, BOLD-100, we carried forward the UPR pathway for further validation. Here, HSPA5 is linked to colorectal cancer.